Position in NEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$788,746
+$552,239 QoQ
Shares Held
106,300
+228.6% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026TWINBEECH CAPITAL LP holds $13,428,259 across 8 Diagnostics & Research names. NEO ranks #4 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
68,803 | $7,842,165 | |
| 2 | SHC |
Sotera Health Co
|
151,952 | $2,178,991 | |
| 3 | DHR |
Danaher Corp /De/
|
4,320 | $819,072 | |
| 4 | NEO |
Neogenomics Inc
This page
|
106,300 | $788,746 | |
| 5 | ADPT |
Adaptive Biotechnologies Corp
|
54,277 | $753,364 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
8,000 | $513,760 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
507 | $284,878 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,450 | $247,283 |
All Filings in NEO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $788,746 | 106,300 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $236,507 | 32,354 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $509,139 | 36,708 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $2,046,892 | 166,414 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $370,493 | 23,055 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $513,922 | 59,689 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $1,965,104 | 161,737 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||